Tirzepatide powder is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for type 2 diabetes treatment and weight management applications. This white powder formulation offers researchers high purity material for scientific studies.
In clinical trials, Tirzepatide has demonstrated superior efficacy compared to selective GLP-1 receptor agonists, with phase 3 studies showing average weight reduction of 15-20.9% over 72 weeks at different dosage levels (5mg, 10mg, 15mg weekly). The compound's unique mechanism combines the metabolic benefits of both GIP and GLP-1 pathways.
Our pharmaceutical grade Tirzepatide powder is supplied in convenient 10mg vials (10 vials per box) with minimum order quantity of 10 vials. The product features PEG modification in its molecular structure (C225H348N48O68) which enhances water solubility while maintaining biological activity.
Researchers investigating tirzepatide powder where to buy will find our material meets strict quality standards for laboratory use. The compound has shown promise in studies examining glucose control mechanisms and weight management pathways.
For those researching tirzepatide powder where to purchase for scientific studies, we emphasize this product is for research applications only. Proper storage conditions include keeping the powder in a cool, dry environment protected from light and moisture to maintain stability.
Clinical data suggests Tirzepatide may offer advantages over single-pathway agonists, with its dual receptor activity potentially leading to improved glycemic control and enhanced weight loss effects compared to GLP-1-only medications.